Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients

Overview of attention for article published in Breast Cancer Research and Treatment, December 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 64 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Circulating Tumor DNA as a Predictive Biomarker for Clinical Outcomes With Margetuximab and Pembrolizumab in Pretreated HER2-Positive Gastric/ Gastroesophageal Adenocarcinoma

Cancer Network, 27 Apr 2023

ABSTRACT PURPOSE. To assess the ability of circulating tumor DNA (ctDNA)-based testing to identify patients with HER2 (encoded…